0001144204-19-047664.txt : 20191008 0001144204-19-047664.hdr.sgml : 20191008 20191008160612 ACCESSION NUMBER: 0001144204-19-047664 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191008 DATE AS OF CHANGE: 20191008 EFFECTIVENESS DATE: 20191008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EYEGATE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001372514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350635 FILM NUMBER: 191142793 BUSINESS ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 781-788-9043 MAIL ADDRESS: STREET 1: 271 WAVERLEY OAKS ROAD STREET 2: SUITE 108 CITY: WALTHAM STATE: MA ZIP: 02452 D 1 primary_doc.xml X0708 D LIVE 0001372514 EYEGATE PHARMACEUTICALS INC 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA MASSACHUSETTS 02452 781-788-9043 DELAWARE None None Corporation true Stephen From 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Executive Officer Director President and CEO Sarah Romano 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Executive Officer CFO Paul Chaney 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Praveen Tyle 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Morton Goldberg 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Peter Greenleaf 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Thomas Hancock 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Bernard Malfroy-Camine 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Steven Boyd 271 Waverley Oaks Road, Suite 108 Waltham MA MASSACHUSETTS 02452 Director Pharmaceuticals Decline to Disclose 06b false 2019-10-02 false true true true false 0 1875000 1875000 0 false 1 0 0 0 Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3. false EYEGATE PHARMACEUTICALS INC /s/ Stephen From Stephen From President and CEO 2019-10-08